6.14
전일 마감가:
$5.37
열려 있는:
$5.52
하루 거래량:
751.97K
Relative Volume:
2.20
시가총액:
$317.37M
수익:
-
순이익/손실:
$-19.90M
주가수익비율:
-11.58
EPS:
-0.53
순현금흐름:
$-19.80M
1주 성능:
+7.53%
1개월 성능:
+36.75%
6개월 성능:
+0.99%
1년 성능:
+59.48%
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
명칭
Diamedica Therapeutics Inc
전화
(763) 496-5454
주소
301 CARLSON PARKWAY, MINNEAPOLIS, MN
DMAC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DMAC
Diamedica Therapeutics Inc
|
6.14 | 277.57M | 0 | -19.90M | -19.80M | -0.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-10-07 | 개시 | H.C. Wainwright | Buy |
2024-04-24 | 재개 | Craig Hallum | Buy |
2023-06-22 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-04-09 | 개시 | Oppenheimer | Outperform |
2021-02-17 | 개시 | ROTH Capital | Buy |
2020-10-30 | 개시 | Guggenheim | Buy |
2020-07-08 | 개시 | Maxim Group | Buy |
2019-04-30 | 개시 | Dougherty & Company | Buy |
2019-03-05 | 개시 | Lake Street | Buy |
모두보기
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
How institutional ownership impacts DiaMedica Therapeutics Inc. stockVolume Spike & Weekly High Momentum Picks - Newser
Full technical analysis of DiaMedica Therapeutics Inc. stockRisk Management & Free Community Consensus Stock Picks - Newser
Is DiaMedica Therapeutics Inc. stock influenced by commodity pricesTrade Performance Summary & Daily Growth Stock Investment Tips - خودرو بانک
Does DiaMedica Therapeutics Inc. have declining or rising EPS2025 Earnings Impact & Safe Investment Capital Preservation Plans - خودرو بانک
Price momentum metrics for DiaMedica Therapeutics Inc. explained2025 Market Overview & Expert Curated Trade Ideas - Newser
Is DiaMedica Therapeutics Inc. forming higher highs and higher lows2025 Institutional Moves & Community Consensus Stock Picks - خودرو بانک
Published on: 2025-09-05 23:26:43 - خودرو بانک
Trend analysis for DiaMedica Therapeutics Inc. this weekWeekly Profit Summary & AI Driven Stock Price Forecasts - Newser
Combining price and volume data for DiaMedica Therapeutics Inc.2025 Big Picture & Low Risk Entry Point Tips - Newser
Ranking DiaMedica Therapeutics Inc. among high performing stocks via toolsRecession Risk & Community Consensus Trade Signals - Newser
Can DiaMedica Therapeutics Inc. sustain its profitabilityGap Up & Weekly Sector Rotation Insights - خودرو بانک
DiaMedica Therapeutics Stock (DMAC) Opinions on Insider Buying and Conference Presentations - Quiver Quantitative
Diamedica Therapeutics shares rise 3.35% premarket after announcing participation in upcoming investor conferences. - AInvest
DiaMedica Therapeutics: Investor Conferences as Catalysts for Biotech Sector Re-Rating - AInvest
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences - AInvest
Using AI based signals to follow DiaMedica Therapeutics Inc.2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Volatility clustering patterns for DiaMedica Therapeutics Inc.July 2025 Summary & Daily Stock Momentum Reports - Newser
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million By Investing.com - Investing.com Canada
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million - Investing.com
Applying Elliott Wave Theory to DiaMedica Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Using data filters to optimize entry into DiaMedica Therapeutics Inc.2025 Retail Activity & Target Return Focused Stock Picks - Newser
Is DiaMedica Therapeutics Inc. forming a bullish divergenceJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - خودرو بانک
Should you hold or exit DiaMedica Therapeutics Inc. now2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Understanding DiaMedica Therapeutics Inc.’s price movementRate Hike & Consistent Income Trade Ideas - Newser
How cyclical is DiaMedica Therapeutics Inc.’s revenue stream2025 Institutional Moves & Daily Market Momentum Tracking - خودرو بانک
Is DiaMedica Therapeutics Inc. stock a top performer YTD2025 Historical Comparison & High Return Stock Watch Alerts - خودرو بانک
Can DiaMedica Therapeutics Inc. hit a new high this monthRisk Management & High Conviction Trade Alerts - Newser
Published on: 2025-09-03 04:58:56 - Newser
Intraday pattern recognizer results for DiaMedica Therapeutics Inc.Quarterly Profit Report & Daily Profit Focused Screening - Newser
Is DiaMedica Therapeutics Inc. stock entering bullish territoryMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Published on: 2025-09-03 08:43:38 - خودرو بانک
Applying Wyckoff theory to DiaMedica Therapeutics Inc. stockShare Buyback & Consistent Income Trade Recommendations - Newser
What to expect from DiaMedica Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Can DiaMedica Therapeutics Inc. disrupt its industryTrade Exit Summary & Entry Point Confirmation Signals - خودرو بانک
Is DiaMedica Therapeutics Inc. stock forming a cup and handleJuly 2025 Weekly Recap & Free Weekly Watchlist of Top Performers - خودرو بانک
Applying chart zones and confluence areas to DiaMedica Therapeutics Inc.2025 Risk Factors & High Win Rate Trade Alerts - Newser
Diamedica Therapeutics shares fall 2.28% intraday after announcing participation in Cantor Global Healthcare Conference. - AInvest
DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference - Business Wire
Automated trading signals detected on DiaMedica Therapeutics Inc.Market Risk Analysis & Weekly Watchlist of Top Performers - Newser
What’s the MACD signal for DiaMedica Therapeutics Inc.2025 Earnings Impact & Fast Moving Market Watchlists - خودرو بانک
Diamedica Therapeutics Inc (DMAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Diamedica Therapeutics Inc 주식 (DMAC) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
STAHLBERG JAN | 10% Owner |
Aug 13 '25 |
Buy |
5.91 |
293,601 |
1,734,918 |
7,058,066 |
STAHLBERG JAN | 10% Owner |
Aug 14 '25 |
Buy |
5.99 |
70,414 |
421,921 |
7,128,480 |
STAHLBERG JAN | 10% Owner |
Aug 20 '25 |
Buy |
5.86 |
71,107 |
416,495 |
7,207,820 |
STAHLBERG JAN | 10% Owner |
Aug 26 '25 |
Buy |
6.00 |
59,648 |
357,888 |
7,713,693 |
STAHLBERG JAN | 10% Owner |
Aug 22 '25 |
Buy |
5.96 |
59,788 |
356,576 |
7,315,780 |
STAHLBERG JAN | 10% Owner |
Aug 27 '25 |
Buy |
6.00 |
50,772 |
304,632 |
7,764,465 |
STAHLBERG JAN | 10% Owner |
Aug 21 '25 |
Buy |
5.96 |
48,172 |
287,028 |
7,255,992 |
STAHLBERG JAN | 10% Owner |
Aug 15 '25 |
Buy |
6.00 |
8,233 |
49,398 |
7,136,713 |
STAHLBERG JAN | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
1,542,857 |
5,400,000 |
6,764,465 |
Von Koch Thomas | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
2,857,142 |
9,999,997 |
8,383,577 |
자본화:
|
볼륨(24시간):